Home / Methylprednisolone / United States
US ATC H02AB04 · updated 2 Nov 2026
Methylprednisolone shortage in United States
Is there a Methylprednisolone shortage in United States?
Yes. As of 2 Nov 2026, 1 Methylprednisolone product is reported short in United States, the first since 16 Jun 2022. No return date has been given. Main reason: other.
Also short in Canada, Germany, Italy, Spain, Austria, Belgium, Japan. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01) | Par Health, USA LLC | 16 Jun 2022 | not given | Other |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).